EXAS ($9.10) continues in modest recovery mode and is now down only 11% from the pre-release share price at Wednesday’s close. The enterprise value is now in the vicinity of $500M.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”